_id
69185b653c536f8df2317c39
Ticker
0O59.LSE
Name
Sanofi SA
Exchange
LSE
Address
46, avenue de la Grande Armée, Paris, France, 75017
Country
UK
Sector
Industry
Currency
EUR
Website
https://www.sanofi.com
Description
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab, as well as a strategic alliance with the Department of Health " Abu Dhabi for the development of global vaccines. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Last Close
82.8
Volume
26399
Current Price
82.4
Change
0.055
Last Updated
2026-01-08T14:41:23.036Z
Image
https://logo.clearbit.com/www.sanofi.com
Ipo Date
-
Market Cap
117637500000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-09-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
563000000
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Bs_currency_symbol
EUR
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
EUR
PE
-
PB
-
ROE
-
ROA
-
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
45
Deep Value Investing Score
0
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
1
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
0
Quality Investing Score
0
Value Investing Score
0
Quarters > 0 > quarter
2023-09-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
563000000
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
EUR
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
2525000000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
EUR
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
45
Quarters > 1 > quarter
2023-06-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
353000000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
30243000000
Quarters > 1 > balance Sheet > property Plant Equipment
11527000000
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
19282000000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
-
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
1435000000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2023-03-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
459000000
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
1995000000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2022-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
910000000
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
10746000000
Quarters > 3 > balance Sheet > inventories
8960000000
Quarters > 3 > balance Sheet > total Current Assets
34111000000
Quarters > 3 > balance Sheet > property Plant Equipment
11684000000
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
6813000000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
23974000000
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
3111000000
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-
Annuals > 0 > income Statement > net Income
-
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
4168000000
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
2006000000
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
10746000000
Annuals > 0 > balance Sheet > inventories
8960000000
Annuals > 0 > balance Sheet > total Current Assets
34111000000
Annuals > 0 > balance Sheet > property Plant Equipment
11684000000
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
6813000000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
23974000000
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
6720000000
Annuals > 0 > cash Flow > depreciation
3365000000
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
10526000000
Annuals > 0 > cash Flow > capital Expenditures
1606000000
Annuals > 0 > cash Flow > cash From Investing
-2075000000
Annuals > 0 > cash Flow > cash From Financing
-5821000000
Annuals > 0 > cash Flow > net Change In Cash
2638000000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
8920000000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
46
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
39175000000
Annuals > 1 > income Statement > cost Of Revenue
12255000000
Annuals > 1 > income Statement > gross Profit
26920000000
Annuals > 1 > income Statement > operating Expenses
-
Annuals > 1 > income Statement > operating Income
8126000000
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
7798000000
Annuals > 1 > income Statement > net Income
6223000000
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
4008000000
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
1558000000
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
20.742820676451817
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
10098000000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
9787000000
Annuals > 1 > balance Sheet > inventories
8715000000
Annuals > 1 > balance Sheet > total Current Assets
30653000000
Annuals > 1 > balance Sheet > property Plant Equipment
11976000000
Annuals > 1 > balance Sheet > total Assets
120242000000
Annuals > 1 > balance Sheet > payables
6180000000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
17123000000
Annuals > 1 > balance Sheet > total Liabilities
51561000000
Annuals > 1 > balance Sheet > equity
68681000000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
6223000000
Annuals > 1 > cash Flow > depreciation
3001000000
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
10522000000
Annuals > 1 > cash Flow > capital Expenditures
1479000000
Annuals > 1 > cash Flow > cash From Investing
-7298000000
Annuals > 1 > cash Flow > cash From Financing
-7056000000
Annuals > 1 > cash Flow > net Change In Cash
-3817000000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
9.060730041787394
Annuals > 1 > ratios > ROA
5.175396284160277
Annuals > 1 > ratios > FCF
9043000000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.23083599234205487
Annuals > 1 > health Score
64
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
37369000000
Annuals > 2 > income Statement > cost Of Revenue
12159000000
Annuals > 2 > income Statement > gross Profit
25210000000
Annuals > 2 > income Statement > operating Expenses
-
Annuals > 2 > income Statement > operating Income
14113000000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
13778000000
Annuals > 2 > income Statement > net Income
12294000000
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
3937000000
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
1807000000
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
37.766597982284786
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
13915000000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
9953000000
Annuals > 2 > balance Sheet > inventories
8352000000
Annuals > 2 > balance Sheet > total Current Assets
33786000000
Annuals > 2 > balance Sheet > property Plant Equipment
10563000000
Annuals > 2 > balance Sheet > total Assets
114413000000
Annuals > 2 > balance Sheet > payables
5295000000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
19745000000
Annuals > 2 > balance Sheet > total Liabilities
51307000000
Annuals > 2 > balance Sheet > equity
63106000000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
12314000000
Annuals > 2 > cash Flow > depreciation
3186000000
Annuals > 2 > cash Flow > change In Working Capital
-325000000
Annuals > 2 > cash Flow > cash From Operations
7418000000
Annuals > 2 > cash Flow > capital Expenditures
1254000000
Annuals > 2 > cash Flow > cash From Investing
3619000000
Annuals > 2 > cash Flow > cash From Financing
-6485000000
Annuals > 2 > cash Flow > net Change In Cash
4488000000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
19.481507305169078
Annuals > 2 > ratios > ROA
10.745282441680578
Annuals > 2 > ratios > FCF
6164000000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.16494955711953757
Annuals > 2 > health Score
74
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
37631000000
Annuals > 3 > income Statement > cost Of Revenue
11976000000
Annuals > 3 > income Statement > gross Profit
25655000000
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
3125000000
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
2822000000
Annuals > 3 > income Statement > net Income
2806000000
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
3834000000
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
121000000
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
8.304323563019851
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
8726000000
Annuals > 3 > balance Sheet > short Term Investments
426000000
Annuals > 3 > balance Sheet > receivables
10083000000
Annuals > 3 > balance Sheet > inventories
7994000000
Annuals > 3 > balance Sheet > total Current Assets
28936000000
Annuals > 3 > balance Sheet > property Plant Equipment
11017000000
Annuals > 3 > balance Sheet > total Assets
112736000000
Annuals > 3 > balance Sheet > payables
5313000000
Annuals > 3 > balance Sheet > short Term Debt
305000000
Annuals > 3 > balance Sheet > long Term Debt
20181000000
Annuals > 3 > balance Sheet > total Liabilities
53802000000
Annuals > 3 > balance Sheet > equity
58934000000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
2806000000
Annuals > 3 > cash Flow > depreciation
3593000000
Annuals > 3 > cash Flow > change In Working Capital
-419000000
Annuals > 3 > cash Flow > cash From Operations
7715000000
Annuals > 3 > cash Flow > capital Expenditures
1323000000
Annuals > 3 > cash Flow > cash From Investing
-1183000000
Annuals > 3 > cash Flow > cash From Financing
-4039000000
Annuals > 3 > cash Flow > net Change In Cash
2502000000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
4.761258356805918
Annuals > 3 > ratios > ROA
2.489000851546977
Annuals > 3 > ratios > FCF
6392000000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.16985995588743324
Annuals > 3 > health Score
56
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > final Score
50
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
89
Prev Liquidities > 1
50
Prev Liquidities > 2
100
Updated At
2026-01-20T22:56:57.939Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-22
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-01-29
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
1.46
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-10-24
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
EUR
Earnings History > 2 > eps Actual
2.91
Earnings History > 2 > eps Estimate
2.7
Earnings History > 2 > eps Difference
0.21
Earnings History > 2 > surprise Percent
7.7778
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-07-31
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
1.59
Earnings History > 3 > eps Estimate
1.64
Earnings History > 3 > eps Difference
-0.05
Earnings History > 3 > surprise Percent
-3.0488
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-04-24
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
1.38
Earnings History > 4 > eps Estimate
1.69
Earnings History > 4 > eps Difference
-0.31
Earnings History > 4 > surprise Percent
-18.3432
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2025-01-30
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
1.31
Earnings History > 5 > eps Estimate
1.48
Earnings History > 5 > eps Difference
-0.17
Earnings History > 5 > surprise Percent
-11.4865
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-10-25
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
2.86
Earnings History > 6 > eps Estimate
2.48
Earnings History > 6 > eps Difference
0.38
Earnings History > 6 > surprise Percent
15.3226
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-07-25
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
1.73
Earnings History > 7 > eps Estimate
1.65
Earnings History > 7 > eps Difference
0.08
Earnings History > 7 > surprise Percent
4.8485
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-04-25
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
1.78
Earnings History > 8 > eps Estimate
1.78
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2024-03-13
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
1.66
Earnings History > 9 > eps Estimate
1.73
Earnings History > 9 > eps Difference
-0.07
Earnings History > 9 > surprise Percent
-4.0462
Earnings History > 10 > period
2023-09-30
Earnings History > 10 > report Date
2023-10-27
Earnings History > 10 > date
2023-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
2.55
Earnings History > 10 > eps Estimate
2.55
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2023-06-30
Earnings History > 11 > report Date
2023-07-28
Earnings History > 11 > date
2023-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
1.74
Earnings History > 11 > eps Estimate
1.74
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2023-03-31
Earnings History > 12 > report Date
2023-04-27
Earnings History > 12 > date
2023-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
2.16
Earnings History > 12 > eps Estimate
2.16
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2022-12-31
Earnings History > 13 > report Date
2023-02-03
Earnings History > 13 > date
2022-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
1.71
Earnings History > 13 > eps Estimate
1.71
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-09-30
Earnings History > 14 > report Date
2022-10-28
Earnings History > 14 > date
2022-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
2.88
Earnings History > 14 > eps Estimate
2.88
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2022-06-30
Earnings History > 15 > report Date
2022-07-28
Earnings History > 15 > date
2022-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
1.73
Earnings History > 15 > eps Estimate
1.73
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2022-03-31
Earnings History > 16 > report Date
2022-04-28
Earnings History > 16 > date
2022-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
1.93
Earnings History > 16 > eps Estimate
1.93
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-12-31
Earnings History > 17 > report Date
2022-02-04
Earnings History > 17 > date
2021-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
1.38
Earnings History > 17 > eps Estimate
1.37
Earnings History > 17 > eps Difference
0.01
Earnings History > 17 > surprise Percent
0.7299
Earnings History > 18 > period
2021-09-30
Earnings History > 18 > report Date
2021-10-28
Earnings History > 18 > date
2021-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
2.18
Earnings History > 18 > eps Estimate
2.17
Earnings History > 18 > eps Difference
0.01
Earnings History > 18 > surprise Percent
0.4608
Earnings History > 19 > period
2021-06-30
Earnings History > 19 > report Date
2021-07-29
Earnings History > 19 > date
2021-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
1.38
Earnings History > 19 > eps Estimate
1.37
Earnings History > 19 > eps Difference
0.01
Earnings History > 19 > surprise Percent
0.7299
Earnings History > 20 > period
2021-03-31
Earnings History > 20 > report Date
2021-04-28
Earnings History > 20 > date
2021-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
1.61
Earnings History > 20 > eps Estimate
1.6
Earnings History > 20 > eps Difference
0.01
Earnings History > 20 > surprise Percent
0.625
Earnings History > 21 > period
2020-12-31
Earnings History > 21 > report Date
2021-02-05
Earnings History > 21 > date
2020-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
1.22
Earnings History > 21 > eps Estimate
1.21
Earnings History > 21 > eps Difference
0.01
Earnings History > 21 > surprise Percent
0.8264
Earnings History > 22 > period
2020-09-30
Earnings History > 22 > report Date
2020-10-29
Earnings History > 22 > date
2020-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
1.83
Earnings History > 22 > eps Estimate
1.82
Earnings History > 22 > eps Difference
0.01
Earnings History > 22 > surprise Percent
0.5495
Earnings History > 23 > period
2020-06-30
Earnings History > 23 > report Date
2020-07-29
Earnings History > 23 > date
2020-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
1.28
Earnings History > 23 > eps Estimate
1.27
Earnings History > 23 > eps Difference
0.01
Earnings History > 23 > surprise Percent
0.7874
Earnings History > 24 > period
2020-03-31
Earnings History > 24 > report Date
2020-04-24
Earnings History > 24 > date
2020-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
1.63
Earnings History > 24 > eps Estimate
1.62
Earnings History > 24 > eps Difference
0.01
Earnings History > 24 > surprise Percent
0.6173
Earnings History > 25 > period
2019-12-31
Earnings History > 25 > report Date
2020-02-06
Earnings History > 25 > date
2019-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
1.34
Earnings History > 25 > eps Estimate
1.33
Earnings History > 25 > eps Difference
0.01
Earnings History > 25 > surprise Percent
0.7519
Earnings History > 26 > period
2019-09-30
Earnings History > 26 > report Date
2019-10-31
Earnings History > 26 > date
2019-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
1.92
Earnings History > 26 > eps Estimate
1.91
Earnings History > 26 > eps Difference
0.01
Earnings History > 26 > surprise Percent
0.5236
Earnings History > 27 > period
2019-06-30
Earnings History > 27 > report Date
2019-07-29
Earnings History > 27 > date
2019-06-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
1.31
Earnings History > 27 > eps Estimate
1.3
Earnings History > 27 > eps Difference
0.01
Earnings History > 27 > surprise Percent
0.7692
Earnings History > 28 > period
2019-03-31
Earnings History > 28 > report Date
2019-04-26
Earnings History > 28 > date
2019-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
1.42
Earnings History > 28 > eps Estimate
1.32
Earnings History > 28 > eps Difference
0.1
Earnings History > 28 > surprise Percent
7.5758
Earnings History > 29 > period
2018-12-31
Earnings History > 29 > report Date
2019-02-07
Earnings History > 29 > date
2018-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
1.1
Earnings History > 29 > eps Estimate
1.09
Earnings History > 29 > eps Difference
0.01
Earnings History > 29 > surprise Percent
0.9174
Earnings History > 30 > period
2018-09-30
Earnings History > 30 > report Date
2018-10-31
Earnings History > 30 > date
2018-09-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
EUR
Earnings History > 30 > eps Actual
1.84
Earnings History > 30 > eps Estimate
1.71
Earnings History > 30 > eps Difference
0.13
Earnings History > 30 > surprise Percent
7.6023
Earnings History > 31 > period
2018-06-30
Earnings History > 31 > report Date
2018-07-31
Earnings History > 31 > date
2018-06-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
EUR
Earnings History > 31 > eps Actual
1.25
Earnings History > 31 > eps Estimate
1.2
Earnings History > 31 > eps Difference
0.05
Earnings History > 31 > surprise Percent
4.1667
Earnings History > 32 > period
2018-03-31
Earnings History > 32 > report Date
2018-04-27
Earnings History > 32 > date
2018-03-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
EUR
Earnings History > 32 > eps Actual
1.28
Earnings History > 32 > eps Estimate
1.11
Earnings History > 32 > eps Difference
0.17
Earnings History > 32 > surprise Percent
15.3153
Earnings History > 33 > period
2017-12-31
Earnings History > 33 > report Date
2018-02-07
Earnings History > 33 > date
2017-12-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
EUR
Earnings History > 33 > eps Actual
1.06
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
1.06
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-09-30
Earnings History > 34 > report Date
2017-11-02
Earnings History > 34 > date
2017-09-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
EUR
Earnings History > 34 > eps Actual
1.25
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
1.25
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2017-06-30
Earnings History > 35 > report Date
2017-07-31
Earnings History > 35 > date
2017-06-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
EUR
Earnings History > 35 > eps Actual
1.35
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
1.35
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2017-03-31
Earnings History > 36 > report Date
2017-04-28
Earnings History > 36 > date
2017-03-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
EUR
Earnings History > 36 > eps Actual
1.42
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
1.42
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-12-31
Earnings History > 37 > report Date
2017-02-08
Earnings History > 37 > date
2016-12-31
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
EUR
Earnings History > 37 > eps Actual
1.25
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
1.25
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-09-30
Earnings History > 38 > report Date
2016-10-28
Earnings History > 38 > date
2016-09-30
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
EUR
Earnings History > 38 > eps Actual
1.79
Earnings History > 38 > eps Estimate
0
Earnings History > 38 > eps Difference
1.79
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2015-06-30
Earnings History > 39 > report Date
2015-06-30
Earnings History > 39 > date
2015-06-30
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
EUR
Earnings History > 39 > eps Actual
0.997
Earnings History > 39 > eps Estimate
-
Earnings History > 39 > eps Difference
0
Earnings History > 39 > surprise Percent
-
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab, as well as a strategic alliance with the Department of Health " Abu Dhabi for the development of global vaccines. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-09-30)
Health Score
* Institutions hold a combined 0.00% of the total shares of Sanofi SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
1.46
Date
2025-09-30
EPS Actual
2.91
EPS Estimate
2.7
EPS Difference
0.21
Surprise Percent
7.7778%
(Last Updated 2023-09-30)
(Last Updated 2023-09-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-09-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2023-09-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.